03 September 2021: Clinical Research
Genital Human Papillomavirus Prevalence and Genotyping Among Males in Putuo District of Shanghai, China 2015–2019
Xiaoxiao Li ACDEG , Fenfen Xiang C , Zixi Chen D , Tao Zhang B , Zhaowei Zhu BC , Mengzhe Zhang BF , Rong Wu DG* , Xiangdong Kang A*DOI: 10.12659/MSM.932093
Med Sci Monit 2021; 27:e932093
Table 1 Detection of HPV genotypes of male patients in a sexually transmitted disease clinic from 2015 to 2019.
| Number of infection types | Positive cases | 2015 (n=203) | 2016 (n=254) | 2017 (n=241) | 2018 (n=248) | 2019 (n=281) | χ2 | P | gamma value |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 487 (39.69%) | 68 (33.50%) | 99 (38.98%) | 117 (48.55%) | 90 (36.29%) | 113 (40.21%) | 0.795 | 0.373 | 0.036 |
| 2 | 191 (15.57%) | 39 (19.21%) | 45 (17.72%) | 25 (10.37%) | 39 (15.73%) | 43 (15.30%) | 1.432 | 0.231 | −0.065 |
| 3 | 71 (5.79%) | 17 (8.37%) | 18 (7.09%) | 11 (4.56%) | 14 (5.65%) | 11 (3.91%) | 4.614 | 0.032 | −0.185 |
| 4 | 37 (3.02%) | 10 (4.93%) | 11 (4.33%) | 4 (1.66%) | 5 (2.02%) | 7 (2.49%) | 3.855 | 0.05 | −0.228 |
| ≥2 | 317 (25.84%) | 68 (33.50%) | 79 (31.10%) | 42 (17.43%) | 61 (24.60%) | 67 (23.84%) | 7.439 | 0.006 | −0.124 |
| Single HR | 67 (5.46%) | 18 (8.87%) | 3 (1.18%) | 16 (6.64%) | 19 (7.66%) | 11 (3.91%) | 0.307 | 0.580 | −0.047 |
| Single LR | 409 (33.33%) | 50 (24.63%) | 86 (33.86%) | 101 (41.91%) | 71 (28.63%) | 101 (35.94%) | 2.544 | 0.111 | 0.067 |
| HR+HR | 30 (2.44%) | 8 (3.94%) | 13 (5.12%) | 2 (0.83%) | 5 (2.02%) | 2 (0.71%) | 9.698 | 0.002 | −0.405 |
| HR+LR | 247 (20.13%) | 49 (24.14%) | 64 (25.20%) | 36 (14.94%) | 46 (18.55%) | 52 (18.51%) | 4.573 | 0.032 | −0.107 |
| LR+LR | 51 (4.16%) | 11 (5.42%) | 12 (4.72%) | 4 (1.66%) | 10 (4.03%) | 14 (4.98%) | 0.052 | 0.820 | −0.020 |
| HR – high risk; LR – low risk. | |||||||||